 | Study programme 2025-2026 | Français | |
| Formes pharmaceutiques innovantes | |||
Learning Activity |
| Code | Lecturer(s) | Associate Lecturer(s) | Subsitute Lecturer(s) et other(s) | Establishment |
|---|---|---|---|---|
| M-PGAL-227 |
|
|
| Language of instruction | Language of assessment | HT(*) | HTPE(*) | HTPS(*) | HR(*) | HD(*) | Term |
|---|---|---|---|---|---|---|---|
| Français | Français | 10 | 0 | 0 | 0 | 0 | Q1 |
Content of Learning Activity
Content of the AA - Innovative pharmaceutical Formulations (10h)
This specific lesson consists in the presentation, description and explanation of specific and innovative new pharmaceutical forms.
The lesson is mainly about recent pharmaceutical compositions for which an intensively research is undertaken for various pharmaceutical applications.
The compositions are generally already in clinical trials but are not yet be submitted for any regulatory approval. Nevertheless, these formulations should become available for patients in short to mid-term.
Required Learning Resources/Tools
slides put on the Moodle platform
Recommended Learning Resources/Tools
Bibliographical references
Other Recommended Reading
Not applicable
Mode of delivery
- Face-to-face
Type of Teaching Activity/Activities
- Cours magistraux
Evaluations
The assessment methods of the Learning Activity (AA) are specified in the course description of the corresponding Educational Component (UE)
Location of learning activity
- Université de Mons - Mons
Location of assessment
- Université de Mons - Mons